July 1, 2010

TARGET Investigator Highlights the Importance of Translating Cancer Research to Patient Care


Cheryl Willman, M.D., is one of those clinical researchers who inspires cancer patients to hope for a cure. A two-time cancer survivor herself, Dr. Willman is passionate about changing the outlook for patients in her community by ensuring that everyone in New Mexico has world-class cancer care. Dr. Willman, now the Director and Chief Executive Officer (CEO) of the University of New Mexico Cancer Center, was one of the first physicians selected for the Physician-Scientist training program at the National Institutes of Health (NIH) — a program devoted to bringing more clinicians into cancer research. Now, almost three decades later, she has been consistently funded by the National Cancer Institute (NCI) to explore the biology and genetics of leukemia and lymphoma.   Link

Tags: In the News, Uncategorized